FDA Introduces AI Platform to Accelerate Scientific Reviews and Modernize Operations
The FDA launched Elsa, a secure AI platform that significantly reduces task times and aims to modernize agency workflows, marking the beginning of several AI initiatives to enhance internal operations and better serve the public.